XML 36 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Data (Tables)
12 Months Ended
Sep. 30, 2013
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Data
(in thousands, except per common share data)
 
Quarter ended
 
Dec. 31
 
March 31
 
June 30
 
Sept. 30
Fiscal 2013
 
 
 
 
 
 
 
Revenue
$
46,991

 
$
48,197

 
$
48,824

 
$
51,369

Gross profit
24,479

 
24,961

 
24,720

 
25,963

Net income (1)(2)(3)(4)
1,230

 
1,000

 
1,528

 
2,047

Net income per common share - basic
0.05

 
0.04

 
0.06

 
0.08

Net income per common share - diluted
0.05

 
0.04

 
0.06

 
0.08

 
 
 
 
 
 
 
 
Fiscal 2012
 
 
 
 
 
 
 
Revenue
$
46,662

 
$
49,016

 
$
47,632

 
$
47,248

Gross profit
24,430

 
25,783

 
25,304

 
24,820

Net income (1)(2)
724

 
2,122

 
2,307

 
2,462

Net income per common share - basic
0.03

 
0.08

 
0.09

 
0.10

Net income per common share - diluted
0.03

 
0.08

 
0.09

 
0.09

(1)
During fiscal 2013 and 2012, we recorded discrete tax benefits of $0.8 million and $1.5 million, respectively. We recorded a benefit of $0.1 million in the first quarter of fiscal 2013 resulting from the release of income tax reserves due to the expiration of the statute of limitations from various U.S. and foreign tax jurisdictions. During the second quarter of fiscal 2013, we recorded a discrete tax benefit of $0.4 million resulting from the enactment of legislation on January 2, 2013 extending the research and development credit for the last three quarters of fiscal 2012. In the third quarter of fiscal 2013, we recorded a benefit of $0.1 million for the release of income tax reserves due to the expiration of the statute of limitations for U.S. Federal income tax for fiscal 2009. In the fourth quarter of fiscal 2013, we recorded $0.2 million for the reversal of tax reserves resulting from expiration of the statute of limitations for state income taxes.
We recorded a benefit of $0.1 million in the first quarter of fiscal 2012 resulting from the release of income tax reserves due to the expiration of the statute of limitations from various U.S. tax jurisdictions. During the third quarter of fiscal 2012, we recorded $1.1 million for additional research and development tax credits identified for fiscal years ended September 30, 2009, 2010 and 2011 from a recently completed research and development tax credit study. During the fourth quarter of fiscal 2012, we recorded $0.3 million relating to expiration of statute of limitations for state income taxes and a reduction in a foreign statutory rate.
(2)
During fiscal 2013, we recorded a business restructuring accrual of $0.4 million ($0.2 million after tax) in the fourth quarter of fiscal 2013. During fiscal 2012, we recorded a business restructuring accrual of $0.2 million ($0.2 million after tax) in the first quarter, $0.1 million ($0.0 million after tax) in the second quarter and $1.0 million ($0.6 million after tax) in the third quarter.
(3)
During the second quarter of fiscal 2013, we recorded a charge of $1.5 million ($1.0 million after tax) for the settlement of a patent infringement lawsuit.
(4)
During the fourth quarter of fiscal 2013, we recorded a charge of $0.4 million ($0.2 million after tax) for impairment of certain intangibles.